Jayne David R.W. 4
4 · Aurinia Pharmaceuticals Inc. · Filed Nov 25, 2024
Insider Transaction Report
Form 4
Jayne David R.W.
Director
Transactions
- Award
Common Shares
2024-11-21+12,135→ 56,499 total - Award
Director Stock Option (right to buy)
2024-11-21+18,641→ 18,641 totalExercise: $8.24Exp: 2034-11-21→ Common Shares (18,641 underlying)
Footnotes (2)
- [F1]Represents grant of Restricted Stock Units (RSUs) payable solely in common shares of the Issuer. The shares subject to the RSUs shall vest one year from date of grant.
- [F2]The options shall vest one year from date of grant.